These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6533212)

  • 1. [Studies on evaluation of recanalization due to coronary thrombolysis in acute myocardial infarction].
    Nagao K; Kanmatsuse K; Kajiwara N
    Nihon Naika Gakkai Zasshi; 1984 Dec; 73(12):1796-804. PubMed ID: 6533212
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of normal coronary infarction after intracoronary thrombolysis with urokinase.
    Watabe S; Uwatoko M; Tsunekawa A; Izumi S; Osugi J; Takatsu F; Ishikawa H; Nagaya T
    Cathet Cardiovasc Diagn; 1983; 9(5):501-5. PubMed ID: 6640666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary thrombolysis by intravenous infusion of recombinant single chain urokinase-type plasminogen activator or recombinant urokinase in baboons: effect on regional blood flow, infarct size and hemostasis.
    Flameng W; Vanhaecke J; Stump DC; Van de Werf F; Holmes W; Guenzler WA; Flohe L; Collen D
    J Am Coll Cardiol; 1986 Jul; 8(1):118-24. PubMed ID: 3086416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recanalization of obstructed coronary artery by intracoronary administration of prostacyclin in patients with acute myocardial infarction.
    Uchida Y; Hanai T; Hasegawa K; Kawamura K; Oshima T
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():377-83. PubMed ID: 6221549
    [No Abstract]   [Full Text] [Related]  

  • 5. Coronary arterial thrombolysis with low-dose synergistic combinations of recombinant tissue-type plasminogen activator (rt-PA) and recombinant single-chain urokinase-type plasminogen activator (rscu-PA) for acute myocardial infarction.
    Collen D; Van de Werf F
    Am J Cardiol; 1987 Sep; 60(7):431-4. PubMed ID: 3115077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracoronary thrombolysis with urokinase in acute myocardial infarction. Effects on reperfusion and left ventricular wall motion.
    Cernigliaro C; Sansa M; Campi A; Sante Bongo A; Rossi P
    G Ital Cardiol; 1982; 12(5):365-73. PubMed ID: 6759286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of double bolus urokinase versus front-loaded alteplase regimen for acute myocardial infarction. Thrombolysis in Myocardial Infarction in Korea (TIMIKO) study group.
    Park SJ
    Am J Cardiol; 1998 Sep; 82(6):811-3, A10. PubMed ID: 9761098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombolysis during acute myocardial infarction.
    Lew AS; Ganz W
    Acute Care; 1985; 11(1):3-39. PubMed ID: 2940795
    [No Abstract]   [Full Text] [Related]  

  • 9. [Efficacy of intracoronary thrombolysis versus percutaneous transluminal coronary angioplasty for treating acute myocardial infarction].
    Nakamura M; Yamaguchi T; Isshiki T; Nagahara T; Itaoka Y; Saeki F
    J Cardiol; 1992; 22(4):607-16. PubMed ID: 1343626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombolysis in acute myocardial infarction.
    Gold HK; Leinbach RC
    Chest; 1988 Jan; 93(1 Suppl):10S-12S. PubMed ID: 2961515
    [No Abstract]   [Full Text] [Related]  

  • 11. Circadian variation in the success rate of intracoronary thrombolysis for acute myocardial infarction.
    Fujita M; Araie E; Yamanishi K; Miwa K; Kida M; Nakajima H
    Am J Cardiol; 1993 Jun; 71(15):1369-71. PubMed ID: 8498385
    [No Abstract]   [Full Text] [Related]  

  • 12. [Intracoronary thrombolysis using urokinase in acute myocardial infarct].
    Kanmatsuse K; Kajwara N; Onikura S; Satoh K; Toda Y
    Ter Arkh; 1982; 54(11):25-7. PubMed ID: 6760435
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fibrinolytic treatment of myocardial infarct or acute coronary insufficiency].
    Cousteau JP
    Sem Hop Ther; 1976 Apr; 52(4):239-41. PubMed ID: 948766
    [No Abstract]   [Full Text] [Related]  

  • 14. Coronary thrombolysis with clot-selective plasminogen activators.
    Collen D; Bounameaux H
    Herz; 1986 Feb; 11(1):9-15. PubMed ID: 3082731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of urokinase in acute myocardial infarction.
    Makolkin VI; Bokarew IN; Buturow VN; Terechow VN; Kuznetzow VA; Seryogina MV; Yarowaya LD
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):394-7. PubMed ID: 2465237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathophysiology and treatment of thrombosis. 3. Prevention and treatment of thrombosis. (1) The role of intracoronary thrombi, platelet function and prostaglandins in the pathogenesis of myocardial infarction; with special reference to intracoronary thrombolysis treatment].
    Kawai C; Yui Y
    Nihon Naika Gakkai Zasshi; 1987 Jan; 76(1):43-8. PubMed ID: 3553380
    [No Abstract]   [Full Text] [Related]  

  • 17. Single-chain urokinase-type plasminogen activators: new hopes for clot-specific lysis.
    Flohé L
    Eur Heart J; 1985 Nov; 6(11):905-8. PubMed ID: 4076201
    [No Abstract]   [Full Text] [Related]  

  • 18. Coronary thrombolysis with intravenous urokinase in patients with acute myocardial infarction.
    Mathey DG; Schofer J; Sheehan FH
    Am J Med; 1987 Aug; 83(2A):26-30. PubMed ID: 3631114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolysis with tissue-type plasminogen activator in acute myocardial infarction. Potentials and pitfalls.
    Jaffe AS; Sobel BE
    JAMA; 1986 Jan; 255(2):237-9. PubMed ID: 3079842
    [No Abstract]   [Full Text] [Related]  

  • 20. Coronary thrombolysis with human single-chain, urokinase-type plasminogen activator (pro-urokinase) in patients with acute myocardial infarction.
    Van de Werf F; Nobuhara M; Collen D
    Ann Intern Med; 1986 Mar; 104(3):345-8. PubMed ID: 3080936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.